Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study will investigate if the drug zoledronic acid given once yearly is safe and has
beneficial effects in treating osteoporosis by reducing bone loss and fractures in men with
osteoporosis.